| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0056 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |